ISN Webinar: Understanding the cardiovascular effects of GLP-1 Receptor Agonists and implications in patients with CKD and cardiovascular disease

This webinar aims to review the various cardiovascular outcome trials of GLP-1 receptor agonists (GLP-1RAs) conducted in patients with cardiovascular risk with or without diabetes and relevance of these findings in managing patients with chronic kidney disease (CKD), diabetes and cardiovascular disease. The session will delve into practical guidance for integrating GLP-1RAs into existing therapeutic strategies for cardiovascular protection in diabetes and CKD.  

Learning objectives:

- Review the various cardiovascular outcome trials of GLP-1 receptor agonists (GLP-1RAs) to date and discuss if there is any difference in the efficacy and risk between the different GLP-1RAs tested.  
- Review the pleotropic mechanisms of cardiovascular protective effects of GLP1-RA.  
- Provide practical guidance on combination therapies: how to incorporate GLP-1RAs into the current foundation therapies for cardiovascular protection in Type 2 diabetes and CKD.  

Further reading:

This webinar is supported by Novo Nordisk.

Angela Yee Moon Y. Wang

Hong Kong

She is current Deputy Chair of ISN North & East Asia Regional Board, Deputy Chair of ISN Education Working Group. Immediate Past President of International Society of Renal Nutrition and Metabolism (ISRNM), Council member of ISPD, Previous Exe Committee member of KDIGO. Also Committee Member of ISN-ACT, Exe Committee Member of SONG. She has served as a workgroup member of international clinical practice guidelines (CPG) including ISPD Prescribing High Quality Goal-Directed PD Guidelines 2020, ISPD-GREX Practice Recommendations on Physical Activity and Exercise in PD 2021 and KDOQI Nutrition Guidelines 2020 and KDIGO anemia guidelines in CKD 2022. She serves on the editorial board of JASN, Kidney Int, CJASN, NDT (theme Editor), Am J Nephrol, Nephron, etc. She has received ISPD John Maher Award 2006 and NKF Joel D. Kopple Award 2018 and Thomas Addis Award, a lifetime award of the ISRNM in Dec 2022. She has published >200 papers, 15 book chapters, delivered >150 invited lectures in international meetings. She is recognized for her research in cardiovascular, metabolic and nutrition complications in CKD. She works in clinical trials.